Terms: = Brain cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2 AND Prognosis
10 results:
1. AMPK-HIF-1α signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth.
Yun HJ; Li M; Guo D; Jeon SM; Park SH; Lim JS; Lee SB; Liu R; Du L; Kim SH; Shin TH; Eyun SI; Park YY; Lu Z; Lee JH
J Exp Clin Cancer Res; 2023 Dec; 42(1):340. PubMed ID: 38098117
[TBL] [Abstract] [Full Text] [Related]
2. Homeobox A3 and KDM6A cooperate in transcriptional control of aerobic glycolysis and glioblastoma progression.
Yang R; Zhang G; Dong Z; Wang S; Li Y; Lian F; Liu X; Li H; Wei X; Cui H
Neuro Oncol; 2023 Apr; 25(4):635-647. PubMed ID: 36215227
[TBL] [Abstract] [Full Text] [Related]
3. The expression of Hexokinase 2 and its hub genes are correlated with the prognosis in glioma.
Huang Y; Ouyang F; Yang F; Zhang N; Zhao W; Xu H; Yang X
BMC Cancer; 2022 Aug; 22(1):900. PubMed ID: 35982398
[TBL] [Abstract] [Full Text] [Related]
4. Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer.
Jiang H; Wei H; Wang H; Wang Z; Li J; Ou Y; Xiao X; Wang W; Chang A; Sun W; Zhao L; Yang S
Cell Death Dis; 2022 Mar; 13(3):206. PubMed ID: 35246504
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive overview of extracellular vesicle proteomics in meningioma: future strategy.
Rana R; Sharma S; Ganguly NK
Mol Biol Rep; 2021 Dec; 48(12):8061-8074. PubMed ID: 34687392
[TBL] [Abstract] [Full Text] [Related]
6. Expression of hypoxia-inducible factor 1α, glucose transporter 1, and hexokinase 2 in primary central nervous system lymphoma and the correlation with the biological behaviors.
Shen N; Wang Y; Sun X; Bai X; He J; Cui Q; Qian J; Zhu H; Chen Y; Xing R; Liu Q; Wu Y; Li J; Lai W; Sun S; Ji N; Liu Y
Brain Behav; 2020 Aug; 10(8):e01718. PubMed ID: 32533646
[TBL] [Abstract] [Full Text] [Related]
7. Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype.
Mack SC; Agnihotri S; Bertrand KC; Wang X; Shih DJ; Witt H; Hill N; Zayne K; Barszczyk M; Ramaswamy V; Remke M; Thompson Y; Ryzhova M; Massimi L; Grajkowska W; Lach B; Gupta N; Weiss WA; Guha A; Hawkins C; Croul S; Rutka JT; Pfister SM; Korshunov A; Pekmezci M; Tihan T; Philips JJ; Jabado N; Zadeh G; Taylor MD
Clin Cancer Res; 2015 Aug; 21(16):3750-8. PubMed ID: 25957288
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.
Sanzey M; Abdul Rahim SA; Oudin A; Dirkse A; Kaoma T; Vallar L; Herold-Mende C; Bjerkvig R; Golebiewska A; Niclou SP
PLoS One; 2015; 10(5):e0123544. PubMed ID: 25932951
[TBL] [Abstract] [Full Text] [Related]
9. Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis.
Palmieri D; Fitzgerald D; Shreeve SM; Hua E; Bronder JL; Weil RJ; Davis S; Stark AM; Merino MJ; Kurek R; Mehdorn HM; Davis G; Steinberg SM; Meltzer PS; Aldape K; Steeg PS
Mol Cancer Res; 2009 Sep; 7(9):1438-45. PubMed ID: 19723875
[TBL] [Abstract] [Full Text] [Related]
10. Histology-based expression profiling yields novel prognostic markers in human glioblastoma.
Dong S; Nutt CL; Betensky RA; Stemmer-Rachamimov AO; Denko NC; Ligon KL; Rowitch DH; Louis DN
J Neuropathol Exp Neurol; 2005 Nov; 64(11):948-55. PubMed ID: 16254489
[TBL] [Abstract] [Full Text] [Related]
